Withdrawal from long-term benzodiazepine use: randomised trial in family practice

By Vicens Catalina   Fiol Francisca   Llobera Joan   Campoamor Francisco   Mateu Catalina   Alegret Santiago   Socías Isabel  

British Journal of General Practice, Vol. 56, Iss. 533, 2006-12 ,pp. : 958-963

Royal College of General Practitioners

Access to resources Recommend Favorite

Systematic review: the effects of long‐term proton pump inhibitor use on serum gastrin levels and gastric histology

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 649-663

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton Pump Inhibitor Therapy and Osteoporosis

By  

Current Drug Safety, Vol. 3, Iss. 3, 2008-01 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1627-1636

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term safety follow‐up of children and adolescents with stroke following participation in a repetitive transcranial magnetic stimulation and constraint‐induced movement therapy clinical trial

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S5, 2015-10 ,pp. : 104-105

John Wiley & Sons Inc

Access to resources Recommend Favorite